← Leaderboards
S Kevin Li
University Of Cincinnati
$7,494,887
Attributed
$7,494,887
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $622.8K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$6,250,462 · 6
FDA$1,244,425 · 2
By mechanism
R01$4,930,826 · 3
U01$1,244,425 · 2
R21$838,597 · 2
R15$481,039 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Cincinnati
Same institution · by research overlap
- Joseph Paul Broderick$95,619,410
- Tanya L Wallace$492,987
Others in their field
Top investigators on “Drug Delivery Systems”
- Wafaa M. El-Sadr · Columbia University Health Sciences$101,800,876
- Myron S Cohen · Family Health International$101,800,876
- Gerald Van Belle · University Of Washington$48,120,734
- David Heimbrook · Leidos Biomedical Research, Inc.$47,325,954
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$38,382,452
- Martin Friedlander · Scripps Research Institute$36,319,942
Research focus
Drug Delivery SystemsPharmaceutical PreparationsIn VivoIn VitroToxic EffectAdverse EffectsTissuesMembraneRouteAffectTechnologyCellsAnimalsIontophoresisHealth Care CostsPropertyMonitorResistanceDoseDesignAge Related Macular DegenerationBaseAnimal ModelEye Diseases
Grant awards (29)
RNA Nanosystem for Posterior Eye Drug Delivery$400,574
R01 · FY2024 · EY · contact PI
RNA Nanosystem for Posterior Eye Drug Delivery$401,253
R01 · FY2023 · EY · contact PI
RNA Nanosystem for Posterior Eye Drug Delivery$395,744
R01 · FY2022 · EY · contact PI
RNA Nanosystem for Posterior Eye Drug Delivery$421,652
R01 · FY2021 · EY · contact PI
Characterization of gingival drug delivery to improve local treatment$481,039
R15 · FY2019 · DE · contact PI
RNA Nanoparticles for Ocular Drug Delivery to the Posterior Eye$193,302
R21 · FY2016 · EY · contact PI
Development of a Dissolution Method for Long-acting Periodontal Drug Products$125,000
U01 · FY2016 · FD · contact PI
Tiered Testing Strategy for Assessing Thermal Effects on Transdermal Products$250,000
U01 · FY2015 · FD · contact PI
RNA Nanoparticles for Ocular Drug Delivery to the Posterior Eye$247,753
R21 · FY2015 · EY · contact PI
Development of a Dissolution Method for Long-acting Periodontal Drug Products$125,000
U01 · FY2015 · FD · contact PI
Tiered Testing Strategy for Assessing Thermal Effects on Transdermal Products$249,995
U01 · FY2014 · FD · contact PI
Tiered Testing Strategy for Assessing Thermal Effects on Transdermal Products$494,430
U01 · FY2013 · FD · contact PI
Iontophoresis to Improve Nail Disease Treatment$230,814
R01 · FY2012 · GM · contact PI
Iontophoresis to Improve Nail Disease Treatment$230,814
R01 · FY2011 · GM · contact PI
Improved Method of Drug Delivery to the Inner Ear$188,616
R21 · FY2011 · DC · contact PI
Iontophoresis to Improve Nail Disease Treatment$233,145
R01 · FY2010 · GM · contact PI
Improved Method of Drug Delivery to the Inner Ear$208,926
R21 · FY2010 · DC · contact PI
Methods & Noninvasive PK Study to Improve Iontophoresis$73,337
R01 · FY2010 · EY · contact PI
Iontophoresis to Improve Nail Disease Treatment$235,500
R01 · FY2009 · GM · contact PI
Methods & Noninvasive PK Study to Improve Iontophoresis$292,144
R01 · FY2008 · EY · contact PI
Methods & Noninvasive PK Study to Improve Iontophoresis$298,106
R01 · FY2007 · EY · contact PI
Methods to Control Transdermal lontophoresis Variability$204,595
R01 · FY2007 · GM · contact PI
Methods & Noninvasive PK Study to Improve Iontophoresis$324,199
R01 · FY2006 · EY · contact PI
Methods to Control Transdermal lontophoresis Variability$210,706
R01 · FY2006 · GM · contact PI
Methods &Noninvasive PK Study to Improve Iontophoresis$280,000
R01 · FY2005 · EY
Methods to Control Transdermal lontophoresis Variability$210,154
R01 · FY2005 · GM
Methods &Noninvasive PK Study to Improve Iontophoresis$44,000
R01 · FY2005 · EY
Methods to Control Transdermal lontophoresis Variability$210,154
R01 · FY2004 · GM
Methods to Control Transdermal lontophoresis Variability$233,935
R01 · FY2003 · GM